Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319.
Kharitonenkov, Alexei⋅Beals, John M⋅Micanovic, Radmila⋅Strifler, Beth A⋅Rathnachalam, Radhakrishnan⋅Wroblewski, Victor J⋅Li, Shun⋅Koester, Anja⋅Ford, Amy M⋅Coskun, Tamer⋅Dunbar, James D⋅Cheng, Christine C⋅Frye, Christopher C⋅Bumol, Thomas F and Moller, David E
PloS one, vol. 8, (no. 3), pp. e58575, 2013. | Journal Article